Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06268197
Other study ID # IRB23-0329
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 16, 2024
Est. completion date December 30, 2024

Study information

Verified date February 2024
Source University of Illinois at Urbana-Champaign
Contact Project Coordinator
Phone 217-265-0741
Email svoss2@illinois.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research is to examine the feasibility and acceptability of an interoception-based yoga program for chronic pain. Interoception involves your ability to feel sensations in your body (such as your heartbeat or muscle tension) as well as how you think about and interpret those sensations. Interoception may be an important component of chronic pain and the research team is studying whether yoga can change how you feel, think about, and interpret sensations in your body.


Recruitment information / eligibility

Status Recruiting
Enrollment 32
Est. completion date December 30, 2024
Est. primary completion date December 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 64 Years
Eligibility Inclusion Criteria: - Self-reported chronic pain lasting = 3 months (such as widespread musculoskeletal pain, fibromyalgia, migraine etc.) - In the past week, has pain interfered with your day-to-day activities? Yes - Self-reported ambulatory ability without an assistive device - Self-reported ability to get on and off the floor without assistance. - No ongoing mind-body practice (<1x/week over the past 6 months). - Physical Activity Readiness Questionnaire Screen Pass or Physician Consent - English-speaking - Able and willing to provide consent - No plans to move or travel outside the area in the next 2 months Exclusion Criteria: - Ages <18 or = 65 at time of screening - Pain lasting < 3 months - In the past week, has pain interfered with your day-to-day activities? No - Use of any assistive device (e.g. cane, walker, wheelchair). - Inability to get on and off the floor without assistance. - A consistent ongoing mind-body practice (mindfulness, yoga, meditation, tai chi, qigong), at least 1x/week over the past 6 months - Physical Activity Readiness Questionnaire Screen Fail or non-consent of physician - Non-English speaking - Non-consent - Plans to move or significant travel outside the area in the next 2 months - Known pregnancy - Recent surgery or acute bone, joint or nerve injury (within the past 6 months) - Severe or progressive neurological conditions such as Parkinson's disease, dementia, multiple sclerosis, or acquired brain injury - Separate pain-related diagnoses: cancer-related pain, complex regional pain syndrome, postural orthostatic tachycardia syndrome, functional neurological/ movement disorders - Active or planned worker's compensation or personal injury claim - Concurrent participation in another interventional study (e.g. physical activity, mind-body or drug trials)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Yoga Intervention
The yoga intervention will consist of twice weekly, in-person, gentle Hatha yoga classes delivered by a certified yoga instructor. Each class will last 60-75 minutes and will include an introduction to the day's topic, an opening breathing/meditation practice, yoga postures, a closing breathing/meditation practice, and end with a savasana pose and intention setting for a home practice.

Locations

Country Name City State
United States University of Illinois Urbana-Champaign Urbana Illinois

Sponsors (1)

Lead Sponsor Collaborator
University of Illinois at Urbana-Champaign

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Interoceptive Accuracy Heartbeat Tracking Task Primary endpoint: 6 weeks
Other Mindfulness Five Facet Mindfulness Questionnaire (FFMQ), planned covariate for interoceptive sensibility Primary endpoint: 6 weeks
Other PROMIS Pain Intensity Short Form 3a, planned covariate for pain interference. Primary endpoint: 6 weeks
Other Quality of Life 36-Item Short Form Health Survey (SF-36) Primary endpoint: 6 weeks
Other Spiritual Wellbeing Functional Assessment of Chronic Illness Therapy - Spiritual Wellbeing Scale (FACIT-Sp12) Primary endpoint: 6 weeks
Other Pain Impact ASCQ Pain Impact Short Form Primary endpoint: 6 weeks
Primary Feasibility Defined as achieving the target recruitment sample (N=25) in a 9-month period, 80% retention (N=20), 70% attendance rate, 70% home practice adherence and no serious adverse events. Primary endpoint: 6 weeks
Primary Acceptability Defined as >5/7 on acceptability questionnaire (1 = unacceptable, 7 = very acceptable) Primary endpoint: 6 weeks
Secondary Interoceptive Sensibility Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2). Will take the mean of 5 MAIA-2 Subscales: attention regulation, emotional awareness, self-regulation, body listening, and trusting as the primary measure of preliminary efficacy. Planned post-hoc analyses will evaluate differential changes in all 8 subscales. Primary endpoint: 6 weeks
Secondary PROMIS Pain Interference Short Form 8a Primary endpoint: 6 weeks
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain